Similarly, Bmal1 overexpression increases the response of colorectal cancer to oxaliplatin in vitro and in vivo and its high expression levels are associated with better outcomes in colorectal cancer patients [56]. The gene discussed is BMAL1; the disease is colorectal cancer.